DaVita
DVA
#1690
Rank
โ‚ฌ10.97 B
Marketcap
171,03ย โ‚ฌ
Share price
0.91%
Change (1 day)
36.99%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): 9,40ย โ‚ฌ

According to DaVita's latest financial reports the company's current EPS (TTM) is 9,47ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 8,71ย โ‚ฌ a decrease over its 2024 EPS that were of 9,50ย โ‚ฌ.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)9,40ย โ‚ฌ7.84%
20258,71ย โ‚ฌ-8.25%
20249,50ย โ‚ฌ44.94%
20236,55ย โ‚ฌ27.26%
20225,15ย โ‚ฌ-35.56%
20217,99ย โ‚ฌ44.1%
20205,54ย โ‚ฌ19.7%
20194,63ย โ‚ฌ540.48%
20180,72ย โ‚ฌ-76.07%
20173,02ย โ‚ฌ-19.31%
20163,74ย โ‚ฌ242.52%
20151,09ย โ‚ฌ-62.87%
20142,94ย โ‚ฌ13.43%
20132,60ย โ‚ฌ8.45%
20122,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
20,93ย โ‚ฌ 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
9,78ย โ‚ฌ 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
16,74ย โ‚ฌ 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
1,66ย โ‚ฌ-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA